WASHINGTON, DC—There’s fresh evidence that off-label use of TAVR devices for pure native aortic valve regurgitation (NAVR) is associated with “not optimal” outcomes, although newer-generation devices, ...

SAN FRANCISCO — Among patients with symptomatic, severe native aortic regurgitation at high surgical risk, the JenaValve Trilogy transcatheter heart valve system (JenaValve Technology) met its primary ...

Aortic insufficiency is a potentially severe condition that affects the heart’s ability to pump blood. There are many possible causes for this condition. Aortic insufficiency is a form of heart valve ...

PARIS -- The early commercial experience with transcatheter aortic valve replacement (TAVR or TAVI) for severe aortic regurgitation appeared promising, though device size issues and conduction ...

Among young adults with aortic regurgitation (AR), those undergoing aortic valve replacement (AVR) before they met standard criteria were more likely to achieve good results from the surgery, a study ...

Please provide your email address to receive an email when new articles are posted on . A transcatheter aortic valve replacement system designed to treat aortic regurgitation exceeded its safety and ...

Aortic valve disease is a condition that occurs when your aorta (the main artery of your body) and left ventricle (the lower left chamber of your heart) malfunction. The aortic valve determines how ...

Announcing a new article publication for Cardiovascular Innovations and Applications journal. Transcatheter aortic valve replacement (TAVR) is currently a widely used option for patients with severe ...

NEW YORK, NY—For patients with pure native aortic regurgitation (AR) who are undergoing TAVI, use of devices tailored to treat the AR seems to provide superior outcomes compared with off-label use of ...

DEAR DR. ROACH: I’ve had a leaky aortic valve for approximately six years. I recently had an echocardiogram using Doppler. The last test I received was three years ago, which came back with a reading ...